Free Trial
Ends Tomorrow! Last Chance to Save $100 on MarketBeat All Access
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Claim $100 Off
Claim MarketBeat All Access Sale Promotion

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$115.01
+0.2%
$114.77
$107.07
$160.27
$32.49B1.222.13 million shs2.04 million shs
Crane stock logo
CR
Crane
$179.71
+2.5%
$177.81
$159.58
$214.31
$10.38B1.15513,839 shs374,903 shs
Danaher Corporation stock logo
DHR
Danaher
$172.12
-0.7%
$183.52
$160.93
$242.80
$121.74B0.815.15 million shs3.00 million shs
Repligen Corporation stock logo
RGEN
Repligen
$115.06
+1.5%
$117.74
$100.99
$175.77
$6.49B1.091.40 million shs722,882 shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
0.00%+2.97%+0.60%-6.44%+5.67%
Crane stock logo
CR
Crane
0.00%+4.65%-0.46%-11.65%+5.33%
Danaher Corporation stock logo
DHR
Danaher
0.00%+6.28%-3.69%-17.86%-7.71%
Repligen Corporation stock logo
RGEN
Repligen
0.00%+11.85%+0.88%-15.20%-4.28%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$115.01
+0.2%
$114.77
$107.07
$160.27
$32.49B1.222.13 million shs2.04 million shs
Crane stock logo
CR
Crane
$179.71
+2.5%
$177.81
$159.58
$214.31
$10.38B1.15513,839 shs374,903 shs
Danaher Corporation stock logo
DHR
Danaher
$172.12
-0.7%
$183.52
$160.93
$242.80
$121.74B0.815.15 million shs3.00 million shs
Repligen Corporation stock logo
RGEN
Repligen
$115.06
+1.5%
$117.74
$100.99
$175.77
$6.49B1.091.40 million shs722,882 shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
0.00%+2.97%+0.60%-6.44%+5.67%
Crane stock logo
CR
Crane
0.00%+4.65%-0.46%-11.65%+5.33%
Danaher Corporation stock logo
DHR
Danaher
0.00%+6.28%-3.69%-17.86%-7.71%
Repligen Corporation stock logo
RGEN
Repligen
0.00%+11.85%+0.88%-15.20%-4.28%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
3.00
Buy$163.7142.35% Upside
Crane stock logo
CR
Crane
3.13
Buy$226.3325.94% Upside
Danaher Corporation stock logo
DHR
Danaher
2.86
Moderate Buy$238.6538.65% Upside
Repligen Corporation stock logo
RGEN
Repligen
2.87
Moderate Buy$166.1544.41% Upside

Current Analyst Ratings Breakdown

Latest DHR, RGEN, A, and CR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/14/2026
Danaher Corporation stock logo
DHR
Danaher
Initiated CoverageOutperform$200.00
5/14/2026
Repligen Corporation stock logo
RGEN
Repligen
Initiated CoverageOutperform$160.00
5/14/2026
Danaher Corporation stock logo
DHR
Danaher
UpgradeModerate Buy
5/14/2026
Repligen Corporation stock logo
RGEN
Repligen
UpgradeModerate Buy
5/7/2026
Repligen Corporation stock logo
RGEN
Repligen
UpgradeSell (D)Sell (D+)
5/6/2026
Repligen Corporation stock logo
RGEN
Repligen
Boost Price TargetOverweight$145.00 ➝ $160.00
5/6/2026
Repligen Corporation stock logo
RGEN
Repligen
Lower Price TargetOverweight$180.00 ➝ $165.00
5/5/2026
Repligen Corporation stock logo
RGEN
Repligen
Reiterated RatingHold$142.00
5/4/2026
Crane stock logo
CR
Crane
DowngradeBuy (B-)Hold (C+)
4/29/2026
Crane stock logo
CR
Crane
UpgradeHoldBuy$200.00 ➝ $215.00
4/28/2026
Crane stock logo
CR
Crane
Reiterated RatingBuy$235.00
(Data available from 5/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$6.95B4.68$6.63 per share17.34$23.78 per share4.84
Crane stock logo
CR
Crane
$2.44B4.25$16.06 per share11.19$33.91 per share5.30
Danaher Corporation stock logo
DHR
Danaher
$24.57B4.96$11.38 per share15.13$74.82 per share2.30
Repligen Corporation stock logo
RGEN
Repligen
$738.26M8.79$3.42 per share33.67$37.33 per share3.08
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$1.30B$4.5325.3917.562.4218.26%24.49%12.83%5/27/2026 (Estimated)
Crane stock logo
CR
Crane
$401.10M$5.5623.8020.971.9313.10%24.45%10.14%7/27/2026 (Estimated)
Danaher Corporation stock logo
DHR
Danaher
$3.61B$5.1733.2918.892.3014.89%10.91%6.94%7/28/2026 (Estimated)
Repligen Corporation stock logo
RGEN
Repligen
$48.89M$0.90127.8547.162.226.73%4.88%3.48%8/4/2026 (Estimated)

Latest DHR, RGEN, A, and CR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/27/2026Q2 2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$1.40N/AN/AN/A$1.80 billionN/A
5/5/2026Q1 2026
Repligen Corporation stock logo
RGEN
Repligen
$0.38$0.48+$0.10$0.15$192.05 million$194.26 million
4/27/2026Q1 2026
Crane stock logo
CR
Crane
$1.44$1.65+$0.21$1.14$672.74 million$696.40 million
4/20/2026Q1 2026
Danaher Corporation stock logo
DHR
Danaher
$1.94$2.06+$0.12$1.45$6.00 billion$5.95 billion
2/25/2026Q1 2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$1.37$1.36-$0.01$1.07$1.81 billion$1.80 billion
2/24/2026Q4 2025
Repligen Corporation stock logo
RGEN
Repligen
$0.44$0.49+$0.05$0.23$192.23 million$197.91 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$1.020.89%+6.58%22.52%9 Years
Crane stock logo
CR
Crane
$1.020.57%N/A18.35%3 Years
Danaher Corporation stock logo
DHR
Danaher
$1.600.93%+12.20%30.95%2 Years
Repligen Corporation stock logo
RGEN
Repligen
N/AN/AN/AN/AN/A

Latest DHR, RGEN, A, and CR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/5/2026
Danaher Corporation stock logo
DHR
Danaher
quarterly$0.400.92%6/26/20266/26/20267/31/2026
5/20/2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
quarterly$0.25500.9%6/30/20266/30/20267/22/2026
4/27/2026
Crane stock logo
CR
Crane
quarterly$0.25500.56%5/29/20265/29/20266/10/2026
2/24/2026
Danaher Corporation stock logo
DHR
Danaher
quarterly$0.400.88%3/27/20263/27/20264/24/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
0.44
2.07
1.59
Crane stock logo
CR
Crane
0.29
1.18
0.88
Danaher Corporation stock logo
DHR
Danaher
0.33
1.87
1.52
Repligen Corporation stock logo
RGEN
Repligen
0.26
9.20
7.78

Institutional Ownership

CompanyInstitutional Ownership
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
N/A
Crane stock logo
CR
Crane
75.14%
Danaher Corporation stock logo
DHR
Danaher
79.05%
Repligen Corporation stock logo
RGEN
Repligen
97.64%

Insider Ownership

CompanyInsider Ownership
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
N/A
Crane stock logo
CR
Crane
2.12%
Danaher Corporation stock logo
DHR
Danaher
10.80%
Repligen Corporation stock logo
RGEN
Repligen
0.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
18,100282.60 millionN/AOptionable
Crane stock logo
CR
Crane
11,00057.75 million55.08 millionOptionable
Danaher Corporation stock logo
DHR
Danaher
60,000707.77 million631.33 millionOptionable
Repligen Corporation stock logo
RGEN
Repligen
2,00056.41 million56.07 millionOptionable

Recent News About These Companies

Repligen: Q1 Earnings Snapshot
Repligen (RGEN) Q1 2026 Earnings Call Transcript

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Agilent Technologies stock logo

Agilent Technologies NYSE:A

$115.01 +0.22 (+0.19%)
Closing price 05/22/2026 03:59 PM Eastern
Extended Trading
$114.22 -0.79 (-0.69%)
As of 05/22/2026 06:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Crane stock logo

Crane NYSE:CR

$179.71 +4.31 (+2.46%)
Closing price 05/22/2026 03:59 PM Eastern
Extended Trading
$179.78 +0.07 (+0.04%)
As of 05/22/2026 05:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Crane Company, together with its subsidiaries, manufactures and sells engineered industrial products in the United States, Canada, the United Kingdom, Continental Europe, and internationally. The company operates in three segments: Aerospace & Electronics, Process Flow Technologies, and Engineered Materials. The Aerospace & Electronics segment supplies critical components and systems, including original equipment and aftermarket parts for commercial aerospace, as well as the military aerospace, defense, and space markets. This segment also offers pressure sensors for aircraft engine control, aircraft braking systems for commercial aircraft and fighter jets, power conversion solutions for spacecraft, and lubrication systems. The Process Flow Technologies segment provides engineered fluid handling equipment for mission-critical applications. It offers process valves and related products, such as lined pipe, fittings and hoses, air-operated diaphragm and peristaltic pumps, instrumentation and sampling systems, valve positioning and control systems, and valve diagnostic and calibration systems; commercial valves; and pumps and systems. The Engineered Materials segment manufactures fiberglass-reinforced plastic panels and coils for use in the manufacturing of recreational vehicles, as well as in commercial and industrial building applications. This segment sells directly to RV, trailer, and truck manufacturers, as well as through distributors and retailers. The company provides its products and solutions to end markets, including commercial and military aerospace, defense, and space; chemical and pharmaceutical production; water and wastewater; non-residential and municipal construction; energy; and other general industrial and consumer-related applications. The company was formerly known as Crane Holdings, Co. Crane Company was founded in 1855 and is based in Stamford, Connecticut.

Danaher stock logo

Danaher NYSE:DHR

$172.12 -1.21 (-0.70%)
Closing price 05/22/2026 03:59 PM Eastern
Extended Trading
$172.24 +0.12 (+0.07%)
As of 05/22/2026 07:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.

Repligen stock logo

Repligen NASDAQ:RGEN

$115.06 +1.69 (+1.49%)
Closing price 05/22/2026 04:00 PM Eastern
Extended Trading
$115.05 -0.01 (-0.01%)
As of 05/22/2026 04:13 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.